共 50 条
- [4] Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients [J]. PROGRES EN UROLOGIE, 2020, 30 (01): : 35 - 40
- [10] Re: Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials [J]. JOURNAL OF UROLOGY, 2021, 206 (04): : 1061 - 1062